8 Coupons
-
Special Offer
-
30% off
-
.
- . in washington before heading to baltimore for saturday's broadcast of .
- eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
![]()
.
.
.
.